How Will Biologics Fit Into Healthcare Reform?: With so many variables, it's hard to predict what kind of market will exist for biologics and other specialty drugs in 2014. Current trends may provide some insight.

The Institute of Medicine says that health benefit packages should be limited by cost, not services, but doesn't address the coverage of biologics. Employers, meanwhile, are thinking about limiting access to high-priced drugs. Yet, industry reports say that biologics are set to dominate drug spend by 2015. Are we moving toward healthcare rationing?